SecBot SecBot
8-K ·Filed Aug 4, 2026

HSIC

HENRY SCHEIN INC
BULLISH
Impact 6/10
Horizonweeks Processed3mo ago SEC0001000228-26-000043
8-K Item 2.02: Earnings release
Actionable Insight ▲ Bullish

The raised guidance and accelerating internal sales growth (4.6% vs 2.5% in Q1) confirm improving operational momentum. Watch for continued execution on value creation initiatives targeting $125M run-rate by year-end and potential further upside to guidance if trends persist.

DirectionBullish
Confidencehigh
Horizonweeks

How the stock moved after the report

⚠ Clustered BULLISH VIEWSTOCK BELOW ENTRY AT T+60
Entry
$89.11
T+0 close · Aug 4, 2026 · via day close
Latest settled
−5.45%
T+60 · $84.25
Vs SPY
−5.83%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Aug 4 $89.11entry
  2. T+1 · 3mo ago +0.54%α +0.74% · $89.59
  3. T+5 · 3mo ago +0.08%α +0.18% · $89.18
  4. T+20 · 3mo ago −0.66%α +0.58% · $88.52
  5. T+60 · 20d ago −5.45%α −5.83% · $84.25
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Henry Schein reported Q2 2026 non-GAAP EPS of $1.27, beating consensus of $1.24 by 2.5%, and revenue of $3.46B, beating $3.37B by 2.6%. The company raised its FY2026 guidance across all metrics: non-GAAP EPS to $5.29-$5.39 (from $5.23-$5.37), sales growth to 4.5%-5.5% (from 3%-5%), and Adjusted EBITDA growth to mid-to-high single digits. Internal sales growth accelerated to 4.6% from 2.5% in Q1, and the company repurchased $200M in stock during the quarter.

Key Financial Metrics

EPS
$1.27
est $1.24 · +2.4%
Revenue
$3.5B
est $3.4B · +2.6% · +6.7% YoY
Rating
beat
Guidance
4.5% to 5.5% growth over 2025
raised
Free Cash Flow
$196.0M
Gross Margin
31.84%

Key Facts

  • Q2 2026 revenue $3.458B, +6.7% YoY (4.6% internal growth)
  • Non-GAAP diluted EPS $1.27 vs $1.10 YoY, +15.5%
  • GAAP diluted EPS $0.82 vs $0.70 YoY, +17.1%
  • Adjusted EBITDA $288M vs $256M YoY, +12.5%
  • Raised FY2026 non-GAAP EPS guidance to $5.29-$5.39 (prior $5.23-$5.37)
  • Raised FY2026 sales growth guidance to 4.5%-5.5% (prior 3%-5%)
  • Raised FY2026 Adjusted EBITDA growth to mid-to-high single digits (prior mid-single digits)
  • Repurchased 2.6M shares for $200M in Q2; $325M YTD; $455M remaining authorization
  • Operating cash flow $242M in Q2; free cash flow ~$196M after capex

Financial Impact

Non-GAAP EPS beat consensus by $0.03 (2.5%); revenue beat by $88M (2.6%); guidance raised modestly across all metrics

revenueepsadjusted EBITDAguidance

Risk Factors

  • Execution risk on restructuring and value creation initiatives
  • Tariff exposure and supply chain disruption
  • Competitive pressures in dental and medical distribution
  • Foreign currency headwinds (1.4% FX benefit in Q2)

Market Snapshot

Exchange
Nasdaq
Sector
Wholesale-Medical, Dental & Hospital Equipment & Supplies
Analyst Consensus
56% bullish (25 analysts)

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 6 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001000228-26-000043
Document: hsic-20260804.htm0001000228-26-000043
Document: 0001000228-26-000043-index-headers.html0001000228-26-000043
Document: 0001000228-26-000043-index.html0001000228-26-000043
Document: 0001000228-26-000043.txt0001000228-26-000043
8-K Data (Synthetic)0001000228-26-000043

Track record

24 reports on HSIC

Performance horizon

4 of 4 bullish or bearish reports moved the stock their way by T+5. Best: +10.65% at T+20 after the Mar 2, 2026 report. 4 of 5 went positive at some point.

Filters
  1. Nov 16, 2026today 8-K Neutral 2/10 Entry price pending
  2. Nov 12, 20264d ago SC 13G/A Bearish 4/10 Entry $86.14 Now $86.22 −0.09% settles Nov 19
  3. Nov 6, 202610d ago 3 Neutral 1/10 Entry $88.41 to $84.96 Now $86.22 −2.48% ▼ −3.90% −2.21% vs SPY
  4. Nov 3, 202613d ago 8-K Bullish 6/10 Entry $82.50 to $88.74 Now $86.22 +4.51% ▲ +7.56% +8.15% vs SPY
  5. Oct 8, 20265w ago 8-K Neutral 3/10 Entry $84.63 to $86.99 Now $86.22 +1.88% ▲ +2.79% +3.07% vs SPY
  6. Sep 22, 20267w ago 8-K Neutral 3/10 Entry $87.43 to $84.97 Now $86.22 −1.38% ▼ −2.81% −1.63% vs SPY
  7. Aug 4, 202614w ago 8-K Bullish 6/10 Viewing Entry $89.11 to $89.18 Now $86.22 −3.24% ▲ +0.08% +0.18% vs SPY
  8. Aug 4, 202614w ago Institutional Cluster Mixed 4/10 Entry $89.11 to $89.18 Now $86.22 −3.24% ▲ +0.08% +0.18% vs SPY
  9. Jul 30, 202615w ago 8-K Neutral 3/10 Entry $85.17 to $88.23 Now $86.22 +1.23% ▲ +3.59% −0.03% vs SPY
  10. Jun 11, 202622w ago Institutional Cluster Mixed 5/10 Entry $81.25 to $79.92 Now $86.22 +6.12% ▼ −1.64% −2.31% vs SPY
Showing 10 of 24

US Market Status

Market Closed · Opens Wed (12h 8m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Aug 4, 2026